KRAS and cancer: Upon mutation (e.g., G245S and R249S) these interactions are lost, thus destabilizing the local conformation of the loop and preventing the binding with DNA.29 Another interesting example is K-Ras, an important pharmacological target with a high rate of mutations in human cancer.